What is Paradigm Biopharmaceuticals Limited?
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 87.85M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.